Elanco Animal Health Incorporated Acquisitions, Net of Cash Acquired
Elanco Animal Health Incorporated (ELAN) reported Acquisitions, Net of Cash Acquired of $76.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired · last filed 2026-08-05
- Elanco Animal Health Incorporated payments to acquire businesses, net of cash acquired for the quarter ending 2024-12-31 was $36.00M.
- Elanco Animal Health Incorporated payments to acquire businesses, net of cash acquired for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- Elanco Animal Health Incorporated payments to acquire businesses, net of cash acquired for the quarter ending 2024-06-30 was $0.00.
- Elanco Animal Health Incorporated payments to acquire businesses, net of cash acquired for the quarter ending 2024-03-31 was $5.00M, a 68.75% decline year-over-year.
- Elanco Animal Health Incorporated payments to acquire businesses, net of cash acquired for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- Elanco Animal Health Incorporated payments to acquire businesses, net of cash acquired for fiscal 2024 was $41.00M, a 115.79% increase from fiscal 2023.
- Elanco Animal Health Incorporated payments to acquire businesses, net of cash acquired for fiscal 2023 was $19.00M.
- Elanco Animal Health Incorporated payments to acquire businesses, net of cash acquired for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
| Period end | Payments to Acquire Businesses, Net of Cash Acquired 3 month | Payments to Acquire Businesses, Net of Cash Acquired 6 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month | Payments to Acquire Businesses, Net of Cash Acquired 9 month as first filed | Payments to Acquire Businesses, Net of Cash Acquired 12 month | Payments to Acquire Businesses, Net of Cash Acquired 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | $76.00M 10-Q · filed 2026-08-05 | |||||
| 2025-12-31 | $0.00 10-K · filed 2026-02-24 | |||||
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | |||||
| 2024-12-31 | $36.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $36.00M derived: sum of 2 quarters · filed 2026-02-24 | $36.00M derived: sum of 3 quarters · filed 2026-02-24 | $41.00M 10-K · filed 2026-02-24 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $5.00M 10-Q · filed 2024-11-07 | $5.00M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $5.00M 10-Q · filed 2024-08-08 | $5.00M derived: sum of 3 quarters · filed 2026-02-24 | $8.00M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2024-03-31 | $5.00M 10-Q · filed 2024-05-08 | $5.00M derived: sum of 2 quarters · filed 2026-02-24 | $8.00M derived: sum of 3 quarters · filed 2026-02-24 | $8.00M derived: sum of 4 quarters · filed 2026-02-24 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $3.00M derived: sum of 2 quarters · filed 2026-02-24 | $3.00M derived: sum of 3 quarters · filed 2026-02-24 | $19.00M 10-K · filed 2026-02-24 | ||
| 2023-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.00M derived: sum of 2 quarters · filed 2024-11-07 | $19.00M 10-Q · filed 2024-11-07 | $19.00M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $16.00M 10-Q · filed 2024-08-08 | $16.00M derived: sum of 3 quarters · filed 2025-02-25 | $16.00M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2023-03-31 | $16.00M 10-Q · filed 2024-05-08 | $16.00M derived: sum of 2 quarters · filed 2025-02-25 | $16.00M derived: sum of 3 quarters · filed 2025-02-25 | $16.00M derived: sum of 4 quarters · filed 2025-02-25 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 10-K · filed 2025-02-25 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $0.00 derived: sum of 2 quarters · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $0.00 10-Q · filed 2023-08-07 | $0.00 derived: sum of 3 quarters · filed 2024-02-26 | $415.00M derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $0.00 derived: sum of 2 quarters · filed 2024-02-26 | $415.00M derived: sum of 3 quarters · filed 2024-02-26 | $415.00M derived: sum of 4 quarters · filed 2024-02-26 | ||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $415.00M derived: sum of 2 quarters · filed 2024-02-26 | $415.00M derived: sum of 3 quarters · filed 2024-02-26 | $342.00M 10-K · filed 2024-02-26 | ||
| 2021-09-30 | $415.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $415.00M derived: sum of 2 quarters · filed 2022-11-08 | $342.00M 10-Q · filed 2022-11-08 | $342.00M derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$73.00M 10-Q · filed 2022-08-08 | -$73.00M derived: sum of 3 quarters · filed 2023-03-01 | $4.93B derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2021-03-31 | -$73.00M 10-Q · filed 2022-05-09 | -$73.00M derived: sum of 2 quarters · filed 2023-03-01 | $4.93B derived: sum of 3 quarters · filed 2023-03-01 | $4.93B derived: sum of 4 quarters · filed 2023-03-01 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $5.00B derived: sum of 2 quarters · filed 2023-03-01 | $5.00B derived: sum of 3 quarters · filed 2023-03-01 | $5.00B 10-K · filed 2023-03-01 | $5.00B 10-K · filed 2021-03-01 | |
| 2020-09-30 | $5.00B derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $5.00B derived: sum of 2 quarters · filed 2021-11-05 | $5.00B 10-Q · filed 2021-11-05 | $5.00B 10-Q · filed 2020-11-06 | $5.00B derived: sum of 4 quarters · filed 2022-02-28 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $0.00 10-Q · filed 2021-08-09 | $200.00K derived: sum of 3 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | $200.00K derived: sum of 2 quarters · filed 2022-02-28 | ||||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $33.00M 10-K · filed 2022-02-28 | $32.80M 10-K · filed 2020-02-28 | |||
| 2019-09-30 | $32.80M 10-Q · filed 2020-11-06 | |||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-08 | |||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $882.10M 10-K · filed 2020-02-28 | ||||
| 2017-09-30 | $882.10M 10-Q · filed 2018-11-08 | |||||
| 2016-12-31 | $45.00M 10-K · filed 2019-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |